1. Home
  2. BHVN vs DHC Comparison

BHVN vs DHC Comparison

Compare BHVN & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$10.76

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

N/A

Current Price

$6.19

Market Cap

1.1B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
BHVN
DHC
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BHVN
DHC
Price
$10.76
$6.19
Analyst Decision
Buy
Buy
Analyst Count
15
2
Target Price
$30.36
$5.75
AVG Volume (30 Days)
2.9M
1.8M
Earning Date
03-02-2026
02-23-2026
Dividend Yield
N/A
0.65%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,537,901,000.00
Revenue This Year
N/A
$4.79
Revenue Next Year
N/A
$3.64
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.10
52 Week Low
$7.48
$2.00
52 Week High
$44.28
$6.25

Technical Indicators

Market Signals
Indicator
BHVN
DHC
Relative Strength Index (RSI) 45.86 71.23
Support Level $10.61 $5.83
Resistance Level $12.90 $6.00
Average True Range (ATR) 0.80 0.21
MACD -0.23 0.02
Stochastic Oscillator 17.66 90.41

Price Performance

Historical Comparison
BHVN
DHC

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

Share on Social Networks: